Berlin - Delayed Quote EUR
Liquidia Corp (LT4.BE)
14.13
-0.12
(-0.84%)
As of 11:00:07 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-93,422
-93,422
-41,564
-28,588
-34,035
Investing Cash Flow
-8,441
-8,441
-11,288
-587
-107
Financing Cash Flow
194,663
194,663
43,248
64,964
26,320
End Cash Position
176,479
176,479
83,679
93,283
57,494
Interest Paid Supplemental Data
--
--
360
1,626
423
Capital Expenditure
-8,449
-8,449
-11,290
-592
-107
Issuance of Capital Stock
138,551
138,551
24,238
54,461
21,710
Issuance of Debt
57,460
57,460
41,744
19,767
10,410
Repayment of Debt
-4,960
-4,960
-24,025
-10,811
-10,830
Free Cash Flow
-101,871
-101,871
-52,854
-29,180
-34,142
12/31/2021 - 10/22/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
D01.SG Belite Bio Inc
54.50
0.00%
ATQP.F Vericel Corporation
34.00
0.00%
A71.F Ascendis Pharma A/S
149.00
-3.25%
PTCT PTC Therapeutics, Inc.
40.65
-18.62%
RPTX Repare Therapeutics Inc.
1.4000
-2.10%
SLNO Soleno Therapeutics, Inc.
76.49
+1.67%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.3700
+3.95%
SRPT Sarepta Therapeutics, Inc.
63.66
+0.24%
PRTG Portage Biotech Inc.
9.81
-4.48%
VRTX Vertex Pharmaceuticals Incorporated
500.19
-0.19%